Preview Mode Links will not work in preview mode

Apr 3, 2025

Featuring perspectives from Dr Kathleen N Moore, Dr David M O’Malley and Dr Alessandro D Santin, moderated by Dr O’Malley, including the following topics:

  • Introduction (0:00)
  • Strategies to Identify Patients with HER2-Positive Gynecologic Cancers — Dr Santin (2:17)
  • Available Data with and Practical Application of HER2-Targeted Therapy for Advanced Gynecologic Cancers — Dr O'Malley (30:24)
  • Identification and Management of Adverse Events with Trastuzumab Deruxtecan — Dr Moore (1:01:53)

CME information and select publications